SOX combined with intraperitoneal perfusion of docetaxel compared with DOS regimen in the first-line therapy for advanced gastric cancer with malignant ascites: a prospective observation

被引：0
|
作者：
Yehong Bin
Dong Lan
Wenguang Bao
Haiyan Yang
Shengsheng Zhou
Fengxiang Huang
Man Wang
Zhigang Peng
机构：
[1] the First Affiliated Hospital of Guangxi Medical University,Department of Oncology
来源：
Trials | / 23卷
关键词：
Advanced gastric cancer; Malignant ascites; Intraperitoneal infusion of chemotherapy; First-line chemotherapy; Docetaxel; S-1; Oxaliplatin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] SOX combined with intraperitoneal perfusion of docetaxel compared with DOS regimen in the first-line therapy for advanced gastric cancer with malignant ascites: a prospective observation
    Bin, Yehong
    Lan, Dong
    Bao, Wenguang
    Yang, Haiyan
    Zhou, Shengsheng
    Huang, Fengxiang
    Wang, Man
    Peng, Zhigang
    TRIALS, 2022, 23 (01)
  • [2] Retrospective analysis of docetaxel, oxaliplatin plus fluorouracil compared with epirubicin, cisplatin and fluorouracil as first-line therapy for advanced gastric cancer
    Yao, Zhihua
    Guo, Hongqiang
    Yuan, Yadong
    Zhao, Yan
    Yao, Shuna
    Xu, Yingjun
    Liu, Lei
    Liu, Tao
    Liu, Yanyan
    Yang, Shujun
    JOURNAL OF CHEMOTHERAPY, 2014, 26 (02) : 117 - 121
  • [3] Retrospective Evaluation of the Efficacy of First-Line Treatment of Advanced Gastric Cancer With Docetaxel and Oxaliplatin
    Mao, Zhi-yuan
    Guo, Xiao-chuan
    Su, Dan
    Wang, Li-jie
    Zhang, Ting-ting
    Bai, Li
    CANCER INVESTIGATION, 2015, 33 (01) : 16 - 21
  • [4] Paclitaxel combined with oxaliplatin as first-line chemotherapy for locally advanced or metastatic gastric cancer
    Shi, Chunmei
    Chen, Qiang
    Shen, Songfei
    Wu, Riping
    Yang, Baoyu
    Liu, Qing
    Xu, Qian
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (05) : 595 - 601
  • [5] Docetaxel plus Oxaliplatin in Combination with Capecitabine as First-Line Treatment for Advanced Gastric Cancer
    Amarantidis, K.
    Xenidis, N.
    Chelis, L.
    Chamalidou, E.
    Dimopoulos, P.
    Michailidis, P.
    Tentes, A.
    Deftereos, S.
    Karanikas, M.
    Karayiannakis, A.
    Kakolyris, S.
    ONCOLOGY, 2011, 80 (5-6) : 359 - 365
  • [6] Docetaxel and Cisplatin Plus Fluorouracil Compared With Modified Docetaxel, Cisplatin, and 5-Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Retrospective Analysis of Single Institution
    Inal, A.
    Kaplan, M. A.
    Kucukoner, M.
    Isikdogan, A.
    NEOPLASMA, 2012, 59 (02) : 233 - 236
  • [7] Paclitaxel combined with capecitabine as first-line chemotherapy for advanced or recurrent gastric cancer
    Yuan, Meiqin
    Yang, Yunshan
    Lv, Wangxia
    Song, Zhengbo
    Zhong, Haijun
    ONCOLOGY LETTERS, 2014, 8 (01) : 351 - 354
  • [8] Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer
    Jinwan Wang
    Ruihua Xu
    Jian Li
    Yuxian Bai
    Tianshu Liu
    Shunchang Jiao
    Guanghai Dai
    Jianming Xu
    Yunpeng Liu
    Nanfeng Fan
    Yongqian Shu
    Yi Ba
    Dong Ma
    Shukui Qin
    Leizhen Zheng
    Weichang Chen
    Lin Shen
    Gastric Cancer, 2016, 19 : 234 - 244
  • [9] Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer
    Kang, Yoon-Koo
    Ryu, Min-Hee
    Yoo, Changhoon
    Chang, Heung-Moon
    Yook, Jeong Hwan
    Oh, Sung Tae
    Kim, Byung Sik
    Kim, Tae Won
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (06) : 1435 - 1443
  • [10] Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer
    Wang, Jinwan
    Xu, Ruihua
    Li, Jian
    Bai, Yuxian
    Liu, Tianshu
    Jiao, Shunchang
    Dai, Guanghai
    Xu, Jianming
    Liu, Yunpeng
    Fan, Nanfeng
    Shu, Yongqian
    Ba, Yi
    Ma, Dong
    Qin, Shukui
    Zheng, Leizhen
    Chen, Weichang
    Shen, Lin
    GASTRIC CANCER, 2016, 19 (01) : 234 - 244
12345